Aurinia Pharmaceuticals Inc (AUPH)

[Zeppo]

So......what happens to the "less healthy" patient, who might be less healthy specifically due to lupus nephritis, in the Phase 3 test? Does this person not have an opportunity to participate in the test? Is this test going to summarize efficacy % in patients with different levels of the affliction?.......just trying to think like an FDA reviewer. Is the current Phase 3 test protocol difficult enough? Any takers?